Centro Oncologico Modenese

Modena 41122

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Myelodysplastic Syndromes

Studies at this site

• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early
• A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care — Completed